Clinical Trial Update: Characteristics and Treatment Experiences of Individuals Using Injectable Semaglutide for Weight Management, a Cross-sectional Time-series Analysis, Multi-country Study.

View source ↗

Summary

A multi-country cross-sectional time-series analysis describing who uses injectable semaglutide for weight management and their treatment experiences. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• WEGOVY (Semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity | Status: ENROLLING_BY_INVITATION